National
Seeking to ‘move Maine forward’ as governor
Recently out, Michaud could make history at the ballot
Having only come out five months ago in several editorials in Maine newspapers, Mike Michaud is new to the club in terms of out public figures.
Nonetheless, he’s on the path to achieving a goal that has never been accomplished by any openly gay person: Winning a gubernatorial election.
During an interview with the Washington Blade in the office of one of his campaign’s consultants near Capitol Hill, Michaud tried to tamp down his sexual orientation as a factor in the race, but acknowledged the significance it places on his candidacy.
“That’s not why I ran for governor, because of my sexual orientation; it’s because I want to move Maine forward,” Michaud said. “But, quite frankly, if elected, it is historic, and I think it’ll also change the tone of the debate when you look at LGBT issues, not only in Maine, but throughout the country.”
The five-term member of Congress is seeking election in a state that legalized marriage equality at the ballot in 2012 and non-discrimination protections for LGBT people in 2005 (after earlier failed attempts).
“As governor, one of the advantages I’ll have is the opportunity to talk with some of my colleagues,” Michaud said. “As a matter of fact, the National Governors Association just met this week. To sit down with some of the governors talking about LGBT issues as it might come up in their particular states is something that I’m not hesitant to do, and it’s easier talking to peer-to-peer.”
As Michaud noted, the State House recently rejected by a 89-52 vote a measure that would carve out a portion of Maine’s civil rights law to allow individuals to discriminate, including on the basis of sexual orientation and gender identity.
It’s similar to a controversial “turn away the gay” bill pending before Arizona Gov. Jan Brewer (R) that would enable individuals and businesses to refuse service based on a sincerely held religious belief.
Michaud said he would veto any such measure that might reach his desk as governor, and furthermore said he believes Brewer “absolutely” should veto the version of the bill in her state. Recalling the recent meeting in D.C. of the National Governors Association, Michaud said “that would be something I would be able to talk with her about this week if I was governor.”
The Gay & Lesbian Victory Fund and Equality Maine have endorsed Michaud’s candidacy. The Human Rights Campaign hasn’t yet officially thrown its support behind him, but is expected to announce more endorsements for Election 2014 following an upcoming board meeting.
Elise Johansen, Equality Maine’s executive director, said a win by Michaud in the gubernatorial election would be historic for the country and the state — and maintained her organization will help him achieve the victory.
“We endorsed Congressman Michaud’s campaign for governor because we strongly believe that he is the best choice to lead Maine, for the LGBT community and everyone in our state.” Johansen said. “In addition to electing a proven leader with a long history of standing with LGBT Mainers, we have the opportunity to make history by electing our nation’s first openly-gay governor.”
No other Democrats are challenging Michaud for the nomination in the race, so he’ll carry the Democratic banner in what could be a three-way race.
On the Republican side is incumbent Gov. Paul LePage, who was first elected during the Tea Party wave in 2010 and was recently dubbed by Politico as “America’s Craziest Governor.” Also in contention is Eliot Cutler, an independent who’s a perennial candidate for Maine governor.
The race will be tight. Cook Political Report rates the contest as a toss-up, while Rothenberg Political Report considers the match toss-up/lean Democrat. Nonetheless, Michaud said the polling he sees in the race is promising.
“I feel pretty good about where we’re at; we’re leading in all the polls head-to-head,” Michaud said. “With our current governor, it’s a slam dunk, with a three-way race it complicates it a little more, but I feel really good about where we’re at.”
Making an impact by being out
Although he’s served in Congress since 2003, Michaud came out in November via a series of editorials published in the Portland Press Herald, the Bangor Daily News and the Associated Press.
“It never was an issue in my campaigns before,” Michaud said. “It appears that someone was trying to make it an issue this time around, so rather than let them make an issue, I decided to come out and move forward.”
The announcement came the same week that the Senate began considering the Employment Non-Discrimination Act, but Michaud said the timing was based on his presence in Maine as well as a pending endorsement from Maine firefighters and policemen. Because those groups tend to be more conservative, the campaign announced the news so those groups wouldn’t rescind their support afterward.
Nonetheless, Michaud said his announcement had a positive impact and recalled a story in which a restaurant owner who had a gay son wanted to speak with him.
“He actually literally had tears in his eyes because his son came out five months before that as gay,” Michaud said. “But the way he came out, he needed help, he was sick and needed help. And the fact that when I came out, it really lifted the spirits of his son.”
Saying the incident made him “feel really good” as he recalled what happened, Michaud said it was just one of several of cases of individuals who have told him it made a big difference.
Now that he’s out, Michaud said he sees no evidence of his sexual orientation being an issue among the candidates in the race — although he said a Tea Party challenger to Sen. Susan Collins (R-Maine) took to Twitter and Facebook to make it an issue.
Although he could be be the first openly gay person elected as governor, Michaud won’t be the first openly gay person to serve as governor. That distinction belongs to former New Jersey Gov. Jim McGreevey, who came out as gay in 2004 amid controversy before resigning.
Michaud is also not the only openly gay person seeking to win election as a governor in 2014. In Maryland, Del. Heather Mizeur is pursuing the Democratic nomination in a contentious primary. The Maine Democrat said he’s never met Mizeur and professed that he’s unaware of McGreevey.
Heading Michaud’s gubernatorial campaign is Matt McTighe, who also ran a successful campaign in 2012 to legalize marriage equality at the ballot in Maine in addition to heading Americans for Workplace Opportunity, a coalition of groups that pushed for passage of the Employment Non-Discrimination Act in the Senate last year.
Michaud said he supported the idea of bringing marriage equality to the ballot in Maine 2012 — despite what he said were persistent concerns among Democratic leadership at the legislature the issue would hamper Democrats at the ballot.
The Maine Democrat recalled a conversation he had with McTighe and then-Equality Maine executive director Betsy Smith before the decision was made to go forward.
“They were concerned where I might fall out on this particular issue, or they just wanted my perspective,” Michaud said. “I remember telling both of them, ‘If not now, when? Because when is the right time? Because in 2014, you’ll probably have the same excuse. Well, we have the governor’s race. We have to win it back. It’s not the right time. So, when is the right time?'”
The gamble paid off. Democrats regained control of the legislature that year, and the marriage equality initiative passed by a 53-47 percent vote, making it the first state ever to approve marriage equality purely through voter-intiatied ballot initiative.
“And I’m very glad they went with the campaign when they went with it,” Michaud said. “The way it was dealt with was it did change the hearts and minds of individuals one by one, and they made the difference.”
Michaud sees opportunity for ENDA
Before Michaud could be elected governor, he’s set to complete his 10th term in office representing Maine’s 2nd congressional district in the U.S. House. One item that remains on his agenda is continued push for passage of the Employment Non-Discrimination Act.
In 2007, Michaud was among the roughly two-dozen Democrats who voted against a version of ENDA that afforded protections only on the basis of sexual orientation after gender identity-related provisions were removed.
“It should be all-inclusive,” Michaud said. “I did vote against it because it was actually weaker than Maine’s law. I wasn’t going to vote for something that was weaker than Maine’s law. I wasn’t going to vote for something that was weaker than what Maine has already had on the books. Actually, Maine Equality encouraged a ‘no’ vote on the legislation.”
Michaud said he was among the members of the LGBT Equality Caucus who participated in a January meeting first reported by the Washington Blade with Speaker John Boehner (R-Ohio) in which ENDA was a topic.
Although gay Rep. Mark Takano (D-Calif.) told the Blade that Boehner said there’s “no way,” ENDA would come up this session, Michaud offered a slightly different version of events that didn’t throw quite as much cold water on the legislation, saying a lame duck effort on the bill remains possible.
“He actually wanted some more information on it, and we’re going to get him the information,” Michaud said. “They might have already sent it over; I’m not sure yet. He said it was highly unlikely that it would happen before the election, so hopefully there is a leeway maybe after the election. Hopefully, we can take it up in the lame duck session.”
Joining other supporters of the bill who say ENDA has sufficient support to pass the Republican-controlled House, Michaud predicted the measure would pass on the floor — if only Republican leadership would allow the legislation to come up.
“When you look at the overwhelming support, I believe that they’ll get that from the Democratic caucus,” Michaud said. “We’ll definitely have Republican support. I feel comfortable in that regard. Clearly, the more advance notice, we can have on it, the more opportunities we’ll be able to convince our colleagues to support it.”
Michaud declined to comment further on the meeting because of its private nature other than to say Boehner was “very gracious to meet with us.” It was the first time Boehner met with the LGBT Equality Caucus. Michaud said that Boehner chose to meet with the caucus even before President Obama granted an audience with the lawmakers.
Meanwhile, the Maine Democrat is adding his voice to others calling on President Obama to take administrative action against LGBT workplace discrimination by signing an executive order.
“It starts that ball moving,” Michaud said. “Until we see what might happen on the House side, since the Senate already passed it. I think it’s a good step in the right direction because if we can’t get it done in Congress, at least by executive order we’ll have 20 to 25 percent of workers covered.”
Michaud said the LGBT Equality Caucus is working on gathering signatures for another letter to President Obama to encourage him to sign the executive order.
Torey Carter, chief operating officer of the Gay & Lesbian Victory Fund, said Michaud’s candidacy is significant.
“Mike Michaud is uniquely qualified to serve as the next governor of Maine,” Carter said. “He is a visionary leader that is a strong voice for fairness, freedom and equality for all Mainers. As a member of Congress, he has been an unwavering supporter of LGBT issues, and if elected he would become the nation’s first out LGBT governor.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
-
Politics3 days agoLGBTQ Democrats say they’re ready to fight to win in 2026
-
District of Columbia2 days agoBrian Footer suspends campaign for Ward 1 D.C. Council seat
-
Chile5 days agoFar-right José Antonio Kast elected Chile’s next president
-
Opinions3 days agoLighting candles in a time of exhaustion

